Search Results

SurgiCase Viewer is intended to be used as a software interface to assist in visualization and communication of treatment options.

SurgiCase Viewer provides functionality to visualize 3D data and to perform measurements on these 3D data, which should allow a clinician to evaluate and communicate about treatment options.

SurgiCase Viewer is intended for use by people active in the medical sector. When used to review and validate treatment options, SurgiCase Viewer is intended to be used in conjunction with other diagnostic tools and expert clinical judgment.

The SurgiCase Viewer can be used by a medical device/service manufacturer/provider or hospital department to visualize 3D data during the manufacturing process of the end-user who is ordering the device/service. This allows the end-user to evaluate and provide feedback on proposals or intermediate steps in the manufacturing of the device or service.

The SurgiCase Viewer is to be integrated with an online Medical Device Data System which is used to process the medical device or service and which is responsible for case management, authorization, authentication, etc.

The data visualized in the SurgiCase Viewer is controlled by the medical device manufacturer using the SurgiCase Viewer in its process. The Device manufacturer will create the 3D data to the end-user and export it to one of the dedicated formats supported by the SurgiCase Viewer. Each of these formats describe the 3D data in STL format with additional meta-data on the 3D models. The SurgiCase Viewer does not alter the 3D data it imports and its functioning is independent of the specific medical indication or product/service it is used for. It's the responsibility of the Medical device company using the SurgiCase Viewer to comply with the applicable medical device regulations.

The Materialise SurgiCase Viewer is a software interface intended for the visualization and communication of treatment options. The provided document is a 510(k) premarket notification summary, which focuses on demonstrating substantial equivalence to predicate devices rather than providing detailed study results on specific acceptance criteria and performance metrics of the device itself.

Based on the provided text, detailed acceptance criteria and the study proving the device meets them, in the typical format of clinical or standalone performance studies, are not extensively described. The document primarily highlights its non-clinical testing for substantial equivalence.

Here's an attempt to extract and synthesize the requested information, noting where specific details are not available in the provided text:

1. Table of Acceptance Criteria and Reported Device Performance

The document does not explicitly present a table of acceptance criteria with corresponding performance metrics like sensitivity, specificity, accuracy, or effect sizes, which are typically seen in clinical performance studies of AI/imaging devices. Instead, the "Performance Data" section refers to "Non-clinical tests" conducted to validate the application for its intended use and determine substantial equivalence.

2. Sample Size for the Test Set and Data Provenance

The document states "Non-clinical tests" were performed. However, it does not specify the sample size used for any test set (e.g., number of cases, number of 3D models). It also does not mention the data provenance (e.g., country of origin, retrospective or prospective nature) as it refers to non-clinical testing, which typically involves technical verification and validation rather than studies on patient data.

3. Number of Experts and Qualifications for Ground Truth

The document does not mention the use of experts to establish ground truth for a test set. This is consistent with its focus on non-clinical testing and substantial equivalence rather than a clinical performance evaluation against expert consensus.

4. Adjudication Method for the Test Set

As no expert ground truth or clinical test set is described, there is no mention of an adjudication method (e.g., 2+1, 3+1, none).

5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

The document does not describe an MRMC comparative effectiveness study comparing human readers with and without AI assistance. Therefore, no effect size for human improvement is provided.

6. Standalone (Algorithm Only) Performance Study

The document does not present a standalone performance study in terms of typical clinical metrics (e.g., sensitivity, specificity) for the algorithm itself. The "non-clinical tests" relate to the device's functional performance and its equivalence to predicates.

7. Type of Ground Truth Used

The document does not specify a "ground truth" type in the context of expert consensus, pathology, or outcomes data. The validation described is focused on functional and performance equivalence during "non-clinical tests," implying a technical or engineering validation against specified requirements or predicate device behavior.

8. Sample Size for the Training Set

The document does not mention a training set sample size. This aligns with the description of "SurgiCase Viewer" as a software interface for visualization and measurements, suggesting it might not be a machine learning or AI algorithm that requires a traditional training set in the same way. It's more of a tool that processes and displays pre-existing 3D data.

9. How Ground Truth for the Training Set Was Established

As no training set is mentioned or implied in the context of machine learning, the document does not describe how ground truth for a training set was established.

Ask a specific question about this device